| abstract |
The invention discloses a new application of compound salvia in preparing a medicine for treating metabolic syndrome. The compound salvia comprises the following components in parts by weight: 225-675 parts of salvia, 70-1100 parts of Panax notoginseng, and 4-12 parts of borneol. The compound Salvia miltiorrhiza of the present invention contains Salvia miltiorrhiza, Panax notoginseng and borneol in a specific content range, and the three components are compatible in appropriate amounts, which has a good therapeutic effect on metabolic syndrome, and provides a new method for the treatment of metabolic syndrome. Chinese medicine selection. |